Literature DB >> 12803468

Epstein-Barr virus DNA is detected in peripheral blood mononuclear cells of EBV-seronegative infants with infectious mononucleosis-like symptoms.

Kazufumi Ikuta1, Kyoko Saiga, Masanori Deguchi, Takeshi Sairenji.   

Abstract

We demonstrated Epstein-Barr virus (EBV) DNA in peripheral blood mononuclear cells (PBMCs) from infants with infectious mononucleosis- (IM) like symptoms. Thirteen of the 17 patients did not have EBV antibodies; however, EBV DNA was detected in 8 PBMC from the 13 seronegative patients by PCR. The 4 patients were retested in 6-12 months later. Three patients were still seronegative; however EBV DNA wasnot detected. One patient seroconverted and EBV DNA could still be detected. The transcript of EBNA1 was detected in one patient, but neither EBNA2 nor LMP2A were detected in all PBMC from the 4 tested patients. Type 1 EBV DNA was detected in 5 PBMC of 7 tested patients, and type 2 EBV DNA was detected in type 1 positive PBMC of one patient as well. The IL-1 beta polymorphism that is reported to be one of the immunological factors of EBV seronegativity revealed no difference in IM-like patients. These results indicated that EBV infection occurs in EBV-seronegative IM-like infants; however, the modes of infection are clearly different from IM.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12803468     DOI: 10.1023/a:1023487413912

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  26 in total

1.  Observations on childhood infections with the Epstein-Barr virus.

Authors:  G Henle; W Henle
Journal:  J Infect Dis       Date:  1970-03       Impact factor: 5.226

2.  Separation of leukocytes from blood and bone marrow. Introduction.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

3.  Detection of A-type and B-type Epstein-Barr virus in throat washings and lymphocytes.

Authors:  A Apolloni; T B Sculley
Journal:  Virology       Date:  1994-08-01       Impact factor: 3.616

4.  Epstein-Barr virus (EBV) infection in infancy.

Authors:  K H Chan; J S Tam; J S Peiris; W H Seto; M H Ng
Journal:  J Clin Virol       Date:  2001-04       Impact factor: 3.168

5.  Generation of EBV-specific CD4+ cytotoxic T cells from virus naive individuals.

Authors:  Barbara Savoldo; Michael L Cubbage; April G Durett; John Goss; M Helen Huls; Zhensheng Liu; Lopez Teresita; Adrian P Gee; Paul D Ling; Malcolm K Brenner; Helen E Heslop; Cliona M Rooney
Journal:  J Immunol       Date:  2002-01-15       Impact factor: 5.422

6.  Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumour cells.

Authors:  M Sugiura; S Imai; M Tokunaga; S Koizumi; M Uchizawa; K Okamoto; T Osato
Journal:  Br J Cancer       Date:  1996-08       Impact factor: 7.640

7.  T-cell-mediated regression of "spontaneous" and of Epstein-Barr virus-induced B-cell transformation in vitro: studies with cyclosporin A.

Authors:  A B Rickinson; M Rowe; I J Hart; Q Y Yao; L E Henderson; H Rabin; M A Epstein
Journal:  Cell Immunol       Date:  1984-09       Impact factor: 4.868

8.  Immunologic properties of Epstein-Barr virus-seronegative adults.

Authors:  W J Jabs; H J Wagner; P Neustock; H Klüter; H Kirchner
Journal:  J Infect Dis       Date:  1996-05       Impact factor: 5.226

9.  Polymorphism of the IL-1 gene complex in Epstein-Barr virus seronegative and seropositive adult blood donors.

Authors:  M Hurme; M Helminen
Journal:  Scand J Immunol       Date:  1998-09       Impact factor: 3.487

10.  A novel form of Epstein-Barr virus latency in normal B cells in vivo.

Authors:  E M Miyashita; B Yang; K M Lam; D H Crawford; D A Thorley-Lawson
Journal:  Cell       Date:  1995-02-24       Impact factor: 41.582

View more
  6 in total

Review 1.  Serological diagnosis of Epstein-Barr virus infection: Problems and solutions.

Authors:  Massimo De Paschale; Pierangelo Clerici
Journal:  World J Virol       Date:  2012-02-12

2.  Prospective Characterization of the Risk Factors for Transmission and Symptoms of Primary Human Herpesvirus Infections Among Ugandan Infants.

Authors:  Soren Gantt; Jackson Orem; Elizabeth M Krantz; Rhoda Ashley Morrow; Stacy Selke; Meei-Li Huang; Joshua T Schiffer; Keith R Jerome; Annet Nakaganda; Anna Wald; Corey Casper; Lawrence Corey
Journal:  J Infect Dis       Date:  2016-02-24       Impact factor: 5.226

3.  Viral infection in acute exacerbation of idiopathic pulmonary fibrosis.

Authors:  Sharon Chao Wootton; Dong Soon Kim; Yasuhiro Kondoh; Eunice Chen; Joyce S Lee; Jin Woo Song; Jin Won Huh; Hiroyuki Taniguchi; Charles Chiu; Homer Boushey; Lisa H Lancaster; Paul J Wolters; Joseph DeRisi; Don Ganem; Harold R Collard
Journal:  Am J Respir Crit Care Med       Date:  2011-02-25       Impact factor: 21.405

4.  Virologic Diagnosis, Viral Monitoring, and Treatment of Epstein-Barr Virus Infectious Mononucleosis.

Authors:  Hal B. Jenson
Journal:  Curr Infect Dis Rep       Date:  2004-06       Impact factor: 3.725

5.  A three year Seroepidemiological and molecular study of Epstein -Barr virus infection among different age groups with hematological malignancies in a Tertiary care centre of North India ( 2017 -2019).

Authors:  Sangram Singh Patel; Sweta Singh; Chinmoy Sahu; Ujjala Ghoshal; Hemant Verma
Journal:  J Family Med Prim Care       Date:  2021-01-30

Review 6.  Epstein-Barr Virus Epidemiology, Serology, and Genetic Variability of LMP-1 Oncogene Among Healthy Population: An Update.

Authors:  Maria K Smatti; Duaa W Al-Sadeq; Nadima H Ali; Gianfranco Pintus; Haissam Abou-Saleh; Gheyath K Nasrallah
Journal:  Front Oncol       Date:  2018-06-13       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.